Emily Walsh Martin, PhD, spoke with Amber Freed, founder and CEO of SLC6A1 Connect, a patient organization focused on accelerating the development of therapies for SLC6A1 patients like her son Maxwell.Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
ASGCT 2026 Abstract Highlights with Emily Walsh Martin, Sanjay D’Souza, and Jason West
The Issue – A Caregiver’s Journey from Development to Treatment with Amber Freed, Founder of SLC6A1 Connect
CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies with Joseph Glorioso and Rita Perlingeiro
The Issue – Prepared under pressure: Navigating the due diligence process with Dr. Ralph Brandenberger
Free AI-powered recaps of ASGCT Podcast Network and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.